Home > Cloud PRWire > NanoViricides testing oral gummy and syrup Covid-19 treatment – Proactive Research Analyst

NanoViricides testing oral gummy and syrup Covid-19 treatment – Proactive Research Analyst

–News Direct–

Proactive research analyst John Savin speaks to Thomas Warner after releasing a new report on NanoViricides Inc (NYSE-A:NNVC), a development-stage company that is creating special-purpose nanomaterials for antiviral therapy. Savin gives an overview of what the company does, as well as its current operations and its financial situation. He highlights that NanoViricides is currently undertaking its first ever clinical trial, of an edible treatment for Covid-19 in India.

Contact Details

Proactive Investors

+1 604-688-8158

[email protected]

View source version on newsdirect.com: https://newsdirect.com/news/nanoviricides-testing-oral-gummy-and-syrup-covid-19-treatment-proactive-research-analyst-811701760

NanoViricides

comtex tracking

COMTEX_436780769/2655/2023-07-13T08:31:33

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Sahyadri Times journalist was involved in the writing and production of this article.